| |
|
|
|
Emmaus Life Sciences Inc.  
|
|
1.28 -0.02 (-0.02%) |
09-18 15:36 |
|
Open: |
1.23 |
Pre close: |
1.3 |
Target:
|
1.68
|
|
High: |
1.3 |
Low: |
1.23 |
Resistance:
|
1.44
1.64
|
|
Volume: |
2,142 |
Market Cap: |
62M |
Support:
|
1.11
0.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.22
 |
MACD |
MACD(12,26):
|
-0.11 |
|
MA(20): |
1.36  |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
1.57 |
Stochastic Oscillator |
%K(14,3):
|
30.24 |
|
MA(250): |
1.80 |
%D(3): |
20.83 |
|
Average Volume(K) |
3-Month: |
2038
|
52-Week |
High:
|
3.25 |
|
10-Days: |
1410 |
Low: |
0.85 |
|
RSI |
RSI(14):
|
41.28 |
Change(%): |
-30.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.089 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
48.47 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-3.2 |
Shares Float (M) |
29.44 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
21.59 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
24.6 |
% Held by Institutions |
0.48 |
|
Forward EPS |
-1.650 |
Gross Profit (p.s.) |
0.295 |
Shares Short (K) |
41 |
|
Book Value (p.s.) |
-0.370 |
EBITDA (p.s.) |
-0.074 |
P/E |
-0.61 |
|
Sales Per Share |
0.497 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.46 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.99 |
P/S |
2.57 |
|
Operating Margin |
-15.20 |
Levered Free Cash Flow
(M) |
9.96 |
P/CF |
-10.36 |
|
|
|
|
|
|
